Investigational Site Number :2680006

Kutaisi 4600

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Crohn's Disease

Studies at this site

• A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease. — Recruiting now
• Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer — Stopped early